DRKS00028896已完成不适用
Breast cancer risk after modern radiotherapy - CRAMER
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 146
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 15 Years 至 one（—）
- 性别
- Female
入选标准
- •1. Cancer diagnosed as of 2006 with upper body-directed radiotherapy treatment using any technique derived from computer tomography-based treatment planning, 2. Hodgkin, other lymphoma and sarcoma patients have top priority for admission, patients with breast cancer, lung cancer or esophageal cancer with radiotherapy radiation to the breast may be included on an individual basis, 3. all quadrants and the central area of ??both breasts can be delineated on the planning computer tomography are (or have previously been) delineated (according to the study plan below described procedure), 4. the radiotherapy dose can be determined for all quadrants (and the central area) of both breasts, 5. at least one of the breast quadrants / central areas is partially in the radiation field
排除标准
- •1. patients who have received posterior radiotherapy for sarcomas, 2. patients who have received palliative radiotherapy, 3. patients less than 15 years old at the time of cancer diagnosis
研究者
相似试验
已完成
不适用
Consequences of radiation therapy in breast cancer in patients with breast implantC50Malignant neoplasm of breastDRKS00004334Klinik für Strahlenheilkunde60
尚未招募
2 期
A study on the optimal sequencing of radiation In breast cancer(NEOORB)CTRI/2024/06/068847All India Institute of Medical Sciences, Jodhpur
已完成
不适用
TOxicity After Radiotherapy in breAst CancEr Survivors (ThORACeS) - A Retrospective Cohort StudyBreast CancerNCT02471079University Medical Center Groningen706
招募中
不适用
Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast CancerBreast Cancer, Familial MaleChemotherapeutic ToxicityImmune Checkpoint InhibitorCDK4/6 InhibitorTrastuzumabPertuzumabPARP InhibitorComplications RadiotherapyNCT06197581Cancer Institute and Hospital, Chinese Academy of Medical Sciences148
已完成
3 期
Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer.Breast CancerNCT00156806AHS Cancer Control Alberta231